Hydroxysteroid (17beta) dehydrogenase 1 expression enhances estrogen action and serves as a potential drug target for reducing estrogen signaling in the uterus and mammary glands

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  2018-01-26

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Ductal Carcinoma in Situ of the Breast

  2018influential reference
• FSH Stimulation promotes progesterone synthesis and output from human granulosa cells without luteinization

  2017cited by this paper
• Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown.

  2017cited by this paper
• Obesity-associated Breast Cancer: Analysis of risk factors.

  2017cited by this paper
• Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.

  2017cited by this paper
• Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk

  2017cited by this paper
• Extended adjuvant endocrine therapy - A standard to all or some?

  2017cited by this paper
• ERα36, a variant of estrogen receptor α, is predominantly localized in mitochondria of human uterine smooth muscle and leiomyoma cells

  2017cited by this paper
• Prognostic and predictive biomarkers in breast cancer: Past, present and future.

  2017cited by this paper
• Plasma prolactin and breast cancer risk: a meta- analysis

  2016cited by this paper
• Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and –resistant breast cancer cells

  2016cited by this paper
• Current knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1).

  2016influential reference
• Polymorphism of HSD17B1 Ser312Gly with Cancer Risk: Evidence from 66,147 Subjects

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases

  2016cited by this paper
• Identifying progression predictors of breast ductal carcinoma in situ

  2016cited by this paper
• All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.

  2015cited by this paper
• Origin of the response to adrenal and sex steroids: Roles of promiscuity and co-evolution of enzymes and steroid receptors.

  2015cited by this paper
• Global Cancer Incidence and Mortality Rates and Trends—An Update

  2015cited by this paper
• Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme.

  2015cited by this paper
• ERα36--Another piece of the estrogen puzzle.

  2015influential reference
• Estrogen receptors in breast carcinogenesis and endocrine therapy.

  2015cited by this paper
• Vaginal Cytology of the Laboratory Rat and Mouse

  2015cited by this paper
• Hydroxysteroid (17β)‐dehydrogenase 1‐deficient female mice present with normal puberty onset but are severely subfertile due to a defect in luteinization and progesterone production

  2015influential reference
• Classical nuclear hormone receptor activity as a mediator of complex biological responses: a look at health and disease.

  2015cited by this paper
• Estrogen receptor β: the guardian of the endometrium.

  2015cited by this paper
• Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current science.

  2015cited by this paper
• Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions.

  2014cited by this paper
• Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant

  2013cited by this paper
• Differential expression of steroidogenic enzymes according to endometriosis type.

  2013cited by this paper
• Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer.

  2013cited by this paper
• The Contribution of 17beta-Hydroxysteroid Dehydrogenase Type 1 to the Estradiol-Estrone Ratio in Estrogen-Sensitive Breast Cancer Cells

  2012cited by this paper
• Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D.

  2012cited by this paper
• Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells.

  2012cited by this paper
• Estrogen biosynthesis and signaling in endometriosis.

  2012cited by this paper
• Association of endometriosis risk and genetic polymorphisms involving biosynthesis of sex steroids and their receptors: an updating meta-analysis.

  2012cited by this paper
• Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7

  2012influential reference
• Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels.

  2012cited by this paper
• Intra-ovarian roles of activins and inhibins.

  2012cited by this paper
• 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration

  2012influential reference
• Hypothesis Prolactin is tumorigenic to human breast: dispelling the myth that prolactin‐induced mammary tumors are rodent‐specific

  2012cited by this paper
• Lead optimization of 17β-HSD1 inhibitors of the (hydroxyphenyl)naphthol sulfonamide type for the treatment of endometriosis.

  2012influential reference
• Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.

  2011influential reference
• Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis

  2011cited by this paper
• Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases.

  2011cited by this paper
• Understanding follicle growth in vivo.

  2010cited by this paper
• The role of the microenvironment in mammary gland development and cancer.

  2010cited by this paper
• Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression

  2010cited by this paper
• Species Used for Drug Testing Reveal Different Inhibition Susceptibility for 17beta-Hydroxysteroid Dehydrogenase Type 1

  2010cited by this paper
• Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future.

  2010cited by this paper
• Intratumoral Estrogen Disposition in Breast Cancer

  2010cited by this paper
• Uterine epithelial estrogen receptor α is dispensable for proliferation but essential for complete biological and biochemical responses

  2010cited by this paper
• Prolactin and Human Tumourogenesis

  2010cited by this paper
• Immunolocalization of estrogen‐producing and metabolizing enzymes in benign breast disease: Comparison with normal breast and breast carcinoma

  2010cited by this paper
• Cell proliferation regulated by estradiol receptor: Therapeutic implications.

  2010influential reference
• Disturbed estrogen and progesterone action in ovarian endometriosis.

  2009cited by this paper
• Precursors of endometrial and ovarian carcinoma

  2009influential reference
• The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative.

  2009cited by this paper
• Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism.

  2009cited by this paper
• Hormone Receptor Dynamics in a Receptive Human Endometrium

  2009cited by this paper
• Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients

  2009cited by this paper
• Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.

  2009cited by this paper
• Activins regulate 17 b -hydroxysteroid dehydrogenase type I transcription in murine gonadotrope cells

  2009cited by this paper
• Integrated view on 17beta-hydroxysteroid dehydrogenases.

  2009influential reference
• In vivo mouse model for analysis of hydroxysteroid (17beta) dehydrogenase 1 inhibitors.

  2009cited by this paper
• Human HSD17B1 expression masculinizes transgenic female mice.

  2009cited by this paper
• Recent advances in 17beta-hydroxysteroid dehydrogenases.

  2009cited by this paper
• Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer

  2008cited by this paper
• Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.

  2008cited by this paper
• Prolactin and Breast Cancer Etiology: An Epidemiologic Perspective

  2008cited by this paper
• HSD17B1 Genetic Variants and Hormone Receptor–Defined Breast Cancer

  2008cited by this paper
• Proliferative effect of androst-4-ene-3,17-dione and its metabolites in the androgen-sensitive LNCaP cell line.

  2008cited by this paper
• Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells.

  2008cited by this paper
• Aromatase expression in women's cancers.

  2008cited by this paper
• Activation of androgens by hydroxysteroid (17beta) dehydrogenase 1 in vivo as a cause of prenatal masculinization and ovarian benign serous cystadenomas.

  2007cited by this paper
• Breast cancer: a candidate gene approach across the estrogen metabolic pathway

  2007cited by this paper
• Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats.

  2007cited by this paper
• Estrogen receptors: how do they signal and what are their targets.

  2007cited by this paper
• Prenatal programming of the female reproductive neuroendocrine system by androgens.

  2006cited by this paper
• Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication.

  2006cited by this paper
• Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.

  2006cited by this paper
• Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme

  2006cited by this paper
• Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

  2006cited by this paper
• Expression of COX-2 and steroid converting enzymes in breast cancer.

  2006cited by this paper
• Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study.

  2006cited by this paper
• Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.

  2006cited by this paper
• Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.

  2006cited by this paper
• 17β-Hydroxysteroid dehydrogenases in human endometrium and its disorders

  2006influential reference
• Endocrine regulation of menstruation.

  2006influential reference
• Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and Neoplasia

  2005cited by this paper
• A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling

  2005influential reference
• Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.

  2005cited by this paper
• Inhibitors of type 1 17β-hydroxysteroid dehydrogenase with reduced estrogenic activity: Modifications of the positions 3 and 6 of estradiol

  2005cited by this paper
• Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

  2004cited by this paper
• A Comparison of the Biological and Clinical Features of Invasive Lobular and Ductal Carcinomas of the Breast

  2004influential reference
• Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

  2004cited by this paper
• Increased expression of type I 17beta-hydroxysteroid dehydrogenase enhances in situ production of estradiol in uterine leiomyoma.

  2004cited by this paper
• Tissue- and time-dependent estrogen receptor activation in estrogen reporter mice.

  2004influential reference
• The biological role of estrogen receptors α and β in cancer

  2004influential reference
• Sources of estrogen and their importance.

  2003cited by this paper

• No citing papers are available for this paper.